Drugs / InViVoCAR1920 mRNA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07321301 | Sep 2025 → Aug 2027 expected | B-cell non-Hodgkin lymphoma | Daihong Liu | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | InViVoCAR1920 mRNA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07321301 ↗ |
| Modality | Messenger RNA (mRNA) | “InViVoCAR1920 mRNA” NCT07321301 ↗ |